Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study

ConclusionsDue to a large placebo response, we were unable to determine if a drug effect was present. However, we did observe substantial improvement in self-reported cognitive symptoms, likely resulting from factors related to participation in the trial rather than specific drug treatment effects.Trial registrationThe study was registered withclinicaltrials.gov (trial registration: NCT02312943).Implications for Cancer SurvivorsThese results suggest that women with pCRCI can exhibit improvement in subjective cognition, with attention paid to symptoms and close follow-up over a short period of time.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research